Peptic Ulcer Testing

Global Peptic Ulcer Testing Market to Reach US$789.0 Million by 2030

The global market for Peptic Ulcer Testing estimated at US$576.1 Million in the year 2024, is expected to reach US$789.0 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$410.6 Million by the end of the analysis period. Growth in the Upper Endoscopy segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$155.1 Million While China is Forecast to Grow at 5.1% CAGR

The Peptic Ulcer Testing market in the U.S. is estimated at US$155.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$124.2 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Glucose Monitoring Devices Market - Key Trends and Drivers Summarized

The market for glucose monitoring devices is experiencing rapid growth, fueled by technological advancements, increasing diabetes prevalence, and a rising emphasis on proactive health management. Global diabetes rates are climbing due to factors such as obesity, aging populations, and lifestyle habits such as poor diet and inactivity, amplifying the need for effective monitoring solutions. Continuous Glucose Monitors (CGMs) have evolved significantly, offering high accuracy and simplicity beyond their original insulin therapy support.

Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they`re expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.

Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.

SCOPE OF STUDY:

The report analyzes the Peptic Ulcer Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Diagnostic Test (Laboratory Tests, Upper Endoscopy, Gastrointestinal Endoscopy); End-Use (Laboratories, Hospitals, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Beckman Coulter Inc.
• Becton Dickinson and Company
• Biohit Oyj
• Biomerica Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• EKF Diagnostics
• Exalenz Bioscience Ltd.
• Halyard Health Inc.
• Kibion AB
• Meridian Bioscience Inc.
• Orion Diagnostica Oy
• Otsuka America Pharmaceutical Inc.
• Quidel Corporation
• Sekisui Diagnostics LLC
• Thermo Fischer Scientific Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.